Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC   ACTAVIS
EQUITY SHARE DATA
    ALEMBIC
Mar-23
ACTAVIS
Dec-18
ALEMBIC/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs8716,126-   
Low Rs5610,818-   
Sales per share (Unadj.) Rs5.03,955.8-  
Earnings per share (Unadj.) Rs3.1-1,274.2-  
Cash flow per share (Unadj.) Rs3.4416.9-  
Dividends per share (Unadj.) Rs2.200-  
Avg Dividend yield %3.10-  
Book value per share (Unadj.) Rs80.916,315.7-  
Shares outstanding (eoy) m256.78332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x14.43.4 422.3%   
Avg P/E ratio x22.7-10.6 -214.7%  
P/CF ratio (eoy) x21.032.3 64.8%  
Price / Book Value ratio x0.90.8 106.6%  
Dividend payout %70.10-   
Avg Mkt Cap Rs m18,2984,480,758 0.4%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m2400-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m1,2721,315,689 0.1%  
Other income Rs m64325,160 2.6%   
Total revenues Rs m1,9151,340,849 0.1%   
Gross profit Rs m29734,478 0.9%  
Depreciation Rs m67562,428 0.0%   
Interest Rs m575,923 0.0%   
Profit before tax Rs m868-578,713 -0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m62-7,334 -0.8%   
Profit after tax Rs m806-423,784 -0.2%  
Gross profit margin %23.42.6 891.4%  
Effective tax rate %7.11.3 561.8%   
Net profit margin %63.4-32.2 -196.7%  
BALANCE SHEET DATA
Current assets Rs m1,721539,627 0.3%   
Current liabilities Rs m838477,372 0.2%   
Net working cap to sales %69.44.7 1,467.0%  
Current ratio x2.11.1 181.7%  
Inventory Days Days5,03820 25,728.4%  
Debtors Days Days67366 1,014.5%  
Net fixed assets Rs m20,324148,929 13.6%   
Share capital Rs m5140-   
"Free" reserves Rs m20,2670-   
Net worth Rs m20,7805,426,601 0.4%   
Long term debt Rs m01,910,903 0.0%   
Total assets Rs m22,0468,483,012 0.3%  
Interest coverage x187.7-6.6 -2,833.8%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.10.2 37.2%   
Return on assets %3.7-4.1 -89.7%  
Return on equity %3.9-7.8 -49.7%  
Return on capital %4.2-4.8 -86.7%  
Exports to sales %1.20-   
Imports to sales %2.40-   
Net fx Rs m-140-   
CASH FLOW
From Operations Rs m389470,046 0.1%  
From Investments Rs m73258,229 0.0%  
From Financial Activity Rs m-464-806,740 0.1%  
Net Cashflow Rs m-2-78,073 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare ALEMBIC With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare ALEMBIC With: ALPA LAB  IND SWIFT LA  GENNEX LAB.  VINEET LABORATORIES  BIOCON   



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.